开发生存时间的新动态预测方法,以分析阿尔茨海默病的短期和长期进展
Chengfeng Zhang1, Shuyu Chen1, Yanjie Wang1
1Department of Biostatistics, School of Public Health (Guangdong Provincial Key Laboratory of Tropical Disease Research), Southern Medical University, Guangzhou 510515, China.
Artificial intelligence in medicine
|April 30, 2025
概括
这项研究引入了在轻度认知障碍 (MCI) 患者中阿尔茨海默病 (AD) 进展的新动态预测模型. 这些模型提高了预测的准确性,帮助及时做出AD干预的临床决定.
科学领域:
- 神经科学是一个神经科学.
- 生物统计学 生物统计学
- 老年学是一门学科.
背景情况:
- 在轻度认知障碍 (MCI) 中精确预测阿尔茨海默病 (AD) 进展对于及时干预至关重要.
- 现有的动态生存模型通常依赖于危险率,这给解释带来了挑战,并要求进行比例危险假设.
研究的目的:
- 在MCI患者中开发和验证AD进展的新动态预测模型.
- 通过利用受限平均生存时间 (RMST) 和贝叶斯联合建模 (JM) 来改进现有方法.
主要方法:
- 建议使用RMST的贝叶斯联合模型 (JM) 来捕获纵向协变轨迹并预测患者的时间到事件.
- 使用ADNI数据库开发了一种基于LM的短期 (LM-ST) 和基于JM的长期 (JM-LT) 动态预测模型.
- 使用蒙特卡洛模拟和内部/外部数据集验证的模型.
主要成果:
- 拟议的JM方法在模拟中表现出优越的预测性能,与静态模型相比.
- 在预测准确度方面,LM-ST和JM-LT模型都显著优于静态RMST模型.
- 为动态预测模型的实际临床应用开发了一个在线网络工具.
结论:
- 新的LM-ST和JM-LT模型为MCI患者的AD进展提供了更好的预测能力.
- 这些模型为AD管理中的医疗决策提供了强大的数据驱动方法.
- 开发的网络工具促进了临床应用,并增强了患者护理策略.
更多相关视频
相关概念视频
01:26Alzheimer's Disease: Overview
328
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
328
01:18Introduction To Survival Analysis
124
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
124
01:21Cancer Survival Analysis
303
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
303
01:22Alzheimer's Disease: Treatment
128
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
128
01:20Actuarial Approach
42
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
42
01:20Comparing the Survival Analysis of Two or More Groups
90
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
90